These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22554886)

  • 1. Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro.
    Alias E; Dharmapatni AS; Holding AC; Atkins GJ; Findlay DM; Howie DW; Crotti TN; Haynes DR
    Acta Biomater; 2012 Aug; 8(8):3104-12. PubMed ID: 22554886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
    Zawawi MS; Dharmapatni AA; Cantley MD; McHugh KP; Haynes DR; Crotti TN
    Biochem Biophys Res Commun; 2012 Oct; 427(2):404-9. PubMed ID: 23000414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.
    Crotti TN; Dharmapatni AA; Alias E; Zannettino AC; Smith MD; Haynes DR
    Arthritis Res Ther; 2012 Nov; 14(6):R245. PubMed ID: 23146195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
    Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T
    Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
    Humphrey MB; Nakamura MC
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide.
    Liu F; Zhu Z; Mao Y; Liu M; Tang T; Qiu S
    Biomaterials; 2009 Mar; 30(9):1756-62. PubMed ID: 19118894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
    J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone.
    Faucheux C; Horton MA; Price JS
    J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
    Yoshida T; Flegler A; Kozlov A; Stern PH
    J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.
    Barrow AD; Raynal N; Andersen TL; Slatter DA; Bihan D; Pugh N; Cella M; Kim T; Rho J; Negishi-Koga T; Delaisse JM; Takayanagi H; Lorenzo J; Colonna M; Farndale RW; Choi Y; Trowsdale J
    J Clin Invest; 2011 Sep; 121(9):3505-16. PubMed ID: 21841309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein.
    Hada N; Okayasu M; Ito J; Nakayachi M; Hayashida C; Kaneda T; Uchida N; Muramatsu T; Koike C; Masuhara M; Sato T; Hakeda Y
    Bone; 2012 Jan; 50(1):226-36. PubMed ID: 22075210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
    Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F
    Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency.
    Wu Y; Torchia J; Yao W; Lane NE; Lanier LL; Nakamura MC; Humphrey MB
    PLoS One; 2007 Jul; 2(7):e586. PubMed ID: 17611621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss.
    Saad S; Dharmapatni AASSK; Crotti TN; Cantley MD; Algate K; Findlay DM; Atkins GJ; Haynes DR
    Acta Biomater; 2016 Jan; 30():311-318. PubMed ID: 26602825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.